GPT and alopecia: Three months after beginning tofacitinib medication, a partial recovery in the alopecia lesions was seen, and a series of tests, including serum glutamic-oxaloacetic transaminase (SGOT, 335 IU/ml), serum glutamic-pyruvic transaminase (SGPT, 414 IU/ml), and alkaline phosphatase (ALP, 253 IU/ml) was requested for her.